Pfizer: COVID-19 Drug trials sharply cut hospitalization, deaths
Share
Copied
00:29
Pharmaceutical giant Pfizer says its experimental antiviral COVID-19 pill has produced positive trial results. The drugmaker says it hopes to get regulatory approval for the easy-to-use drug in weeks or months.